[Global brain metastases management strategy: a multidisciplinary-based approach].
暂无分享,去创建一个
S. Taillibert | N. Reyns | F. Barlesi | J. Spano | P. Metellus | F. Dhermain | É. Le Rhun | A. Carpentier | G. Noël | D. Azria | A. Tallet
[1] K. Black,et al. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. , 2017, The Cochrane database of systematic reviews.
[2] Alexander van Oudenaarden,et al. Genetic and phenotypic diversity in breast tumor metastases. , 2014, Cancer research.
[3] Thomas Bachelot,et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). , 2014, The Lancet. Oncology.
[4] M. Parmar,et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).
[5] R. Dziadziuszko,et al. Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain , 2012, Breast Cancer Research.
[6] F. Barlesi,et al. Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment , 2012, Radiation oncology.
[7] H. Aoyama,et al. The Role of Whole Brain Radiation Therapy for the Management of Brain Metastases in the Era of Stereotactic Radiosurgery , 2012, Current Oncology Reports.
[8] R. Balleine,et al. HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis , 2011, Breast Cancer Research and Treatment.
[9] Tarek Mekhail,et al. Adjuvant Whole-Brain Radiotherapy Versus Observation after Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study , 2011, Current oncology reports.
[10] P. Brown,et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.
[11] Walter Curran,et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. , 2008, International journal of radiation oncology, biology, physics.
[12] Hiroki Shirato,et al. Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .
[13] Maria Werner-Wasik,et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.
[14] F. Lohr,et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Richard J. Kryscio,et al. Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain , 1998 .
[16] C. Nieder,et al. Tumor-related prognostic factors for remission of brain metastases after radiotherapy. , 1997, International journal of radiation oncology, biology, physics.
[17] L Gaspar,et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.
[18] Ronald Brand,et al. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.
[19] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[20] M. Campone,et al. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. , 2013, The Lancet. Oncology.
[21] S. McGovern. Factors influencing survival in patients with breast cancer and single or solitary brain metastasis , 2012 .
[22] R. Gelber,et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.